200 related articles for article (PubMed ID: 26677895)
41. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Jung HA; Augsburger LL
Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
[TBL] [Abstract][Full Text] [Related]
42. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
[TBL] [Abstract][Full Text] [Related]
43. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
[TBL] [Abstract][Full Text] [Related]
44. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
45. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
[TBL] [Abstract][Full Text] [Related]
46. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
Suzuki T; Kurano T; Kanazawa T; Suzuki N
Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
[TBL] [Abstract][Full Text] [Related]
47. Development and evaluation of novel antihypertensive orodispersible tablets.
Khan HU; Hanif M; Sarfraz RM; Maheen S; Afzal S; Sher M; Afzal K; Mahmood A; Shamim A
Pak J Pharm Sci; 2017 Sep; 30(5):1557-1565. PubMed ID: 29084673
[TBL] [Abstract][Full Text] [Related]
48. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics.
Sharma D; Singh G; Kumar D; Singh M
J Drug Deliv; 2015; 2015():640529. PubMed ID: 25810924
[TBL] [Abstract][Full Text] [Related]
49. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
50. INFLUENCE OF CARBOXYMETHYLCELLULOSE SODIUM AND LUTROL ON THE SWELLING INDEX AND DISINTEGRATION TIME OF BIOMUCOADHESIVE TABLETS WITH MICONAZOLE NITRATE.
Birsan M; Scutariu MM; Cojocaru I
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):445-51. PubMed ID: 27483733
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
[TBL] [Abstract][Full Text] [Related]
52. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
[TBL] [Abstract][Full Text] [Related]
54. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
Sammour OA; Hammad MA; Megrab NA; Zidan AS
AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
[TBL] [Abstract][Full Text] [Related]
55. Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach.
Patel D; Shah M; Shah S; Shah T; Amin A
PDA J Pharm Sci Technol; 2008; 62(3):224-32. PubMed ID: 18661871
[TBL] [Abstract][Full Text] [Related]
56. A new apparatus for real-time assessment of the particle size distribution of disintegrating tablets.
Quodbach J; Kleinebudde P
J Pharm Sci; 2014 Nov; 103(11):3657-3665. PubMed ID: 25223505
[TBL] [Abstract][Full Text] [Related]
57. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
Hackl E; Ermolina I
AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
[TBL] [Abstract][Full Text] [Related]
58. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
[TBL] [Abstract][Full Text] [Related]
59. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
60. Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets.
Chue P; Prinzo RS; Binder CE
Hum Psychopharmacol; 2007 Jul; 22(5):307-14. PubMed ID: 17487933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
